Laura Blouin

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Journal: Cancer research

Published: January 12, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Journal: Cancer research

Published: January 12, 2026

Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients.

Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 24, 2024

Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials.

Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials.

Journal: NPJ precision oncology

Published: March 15, 2024

Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.

Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.

Journal: Molecular cancer

Published: July 06, 2023

Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).

Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 30, 2022

Circulating tumour DNA sequencing reveal mechanisms of resistance to BRAF-targeted therapies in BRAF-mutated gastrointestinal stromal tumour.

Circulating tumour DNA sequencing reveal mechanisms of resistance to BRAF-targeted therapies in BRAF-mutated gastrointestinal stromal tumour.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 18, 2022

Characterization of the novel HLA-DRB1*11:282 allele by sequencing-based typing.

Characterization of the novel HLA-DRB1*11:282 allele by sequencing-based typing.

Journal: HLA

Published: May 06, 2021

Characterization of the novel HLA-A*36:12 allele by sequencing-based typing.

Characterization of the novel HLA-A*36:12 allele by sequencing-based typing.

Journal: HLA

Published: May 06, 2021

Characterization of the novel HLA-A*01:367 allele by sequencing-based typing.

Characterization of the novel HLA-A*01:367 allele by sequencing-based typing.

Journal: HLA

Published: May 06, 2021

Characterization of the novel HLA-DQA1*03:20 allele by sequencing-based typing.

Characterization of the novel HLA-DQA1*03:20 allele by sequencing-based typing.

Journal: HLA

Published: May 06, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026